Growth-seeking electronics giants Samsung, Fujifilm, and IBM investing billions to invade biopharma

We’ve long tracked the trend of food and consumer packaged goods (CPG) companies like Unilever and Clinique (see the November 25, 2008 LRBJ and the report “How to Evaluate Emerging Targeted Delivery Technologies”) entering the medical delivery space. But a more unlikely cross-industry combination is...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

23andMe expands portfolio of approved cancer screenings with latest FDA approval

News Commentary | January 13, 2022

The U.S. FDA has given 23andMe approval to expand its genetic health risk report by screening for a G84E mutation in the HOXB13 gene. This mutation has been linked to an increase in prostate cancer. A recent study showed that males with a G84E gene mutation were 66% more likely to have prostate ... To read more, click here.

Akili Interactive is going public, expected to net USD 412 million and open up investment opportunities

News Commentary | February 01, 2022

The company will be going public through a special purpose acquisition company known as Social Capital Suvretta Holdings Corp. Akili Interactive will use the expected cash proceeds to support the rollout of their U.S. FDA‑approved pediatric ADHD therapeutic, EndeavorRx. With EndeavorRX, Akili is ... Not part of subscription

Brightseed raises USD 68 million to accelerate discovery and novel functional ingredient commercialization

News Commentary | May 11, 2022

Brightseed secured USD 68 million in funding led by Temasek to allow their artificial intelligence‑backed discovery tool "Forager" to continue mining healthful compounds in waste streams and grow partnerships like the one established with Danone. The biggest change will come if the company is able ... Not part of subscription